David Rosmarin, MD
Invited Speaker: Efficacy and Safety of Ruxolitinib Cream for the Treatment of Vitiligo: 24-Week Results From 2 Randomized, Double-Blind Phase 3 Studies
Prashant Giri, MSc
Altered Calcium-NFAT Signaling Pathway May Be Responsible for Decreased Suppressive Capacity of Tregs in Generalized Vitiligo Patients
Janice Nathalie, MD
Health-Related Quality of Life in Pediatric Patients With Vitiligo
Thierry Passeron, MD, PhD Oral Abstract
Increased Cutaneous Activation of Innate Immunity and Pro-apoptotic CXCR3B in Patients With Segmental Vitiligo
Davinder Parsad, MD
Invited Speaker: Stabilizing Treatment Options in Vitiligo
Andrew Thompson, DClinPsy
The Association Between Mental Health Conditions and Vitiligo: A Population-Based Cohort Study in the UK
Nanis Ragab, MD
Early Localized Vitiligo, a Medical Emergency: Long Term Follow up Study
Jessica Shiu, MD, PhD
Multimodal Analyses of Stable Vitiligo Skin Identify Tissue Interactions That Control Disease Persistence
Poster Session Q&A #3
Laila Benzekri, MD
Avina Jain, MBBS, MD
Reenu T. George, MD
Prakhar Srivastava, MBBS, MD
Samia Esmat, MD
Vitiligo Treatment: Patient’s or Doctor’s Decision ?!!